For years, AI drug discovery has been judged on benchmark performance. Now, a set of studies shows what happens when those ...

Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration (FDA) has debuted a framework that is designed to help companies move away from the use of non ...

At the 2026 AngloNordic conference, Merck KGaA’s chief science and technology officer Laura Matz announced plans to replace most of the company’s animal testing with new approach methodologies (NAMs) ...

Add Yahoo as a preferred source to see more of our stories on Google. The EMA now deems virtual animal controls as scientifically valid in the preclinical testing context. Credit: Egoreichenkov ...

Merck KGaA has announced plans to replace most of its animal testing protocols with new approach methodologies (NAMs), aligning with a global regulatory shift toward human-relevant models. Experts at ...

Rutherford, NJ, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes ...

MED Institute, a leader in pre-clinical and clinical medical product development services, is proud to announce a strategic collaboration with Sus Clinicals, a pioneering provider of genetic-modified ...

Researchers at the University of Plymouth are leading an innovative initiative to advance the study of meningiomas in NF2-related schwannomatosis (NF2-SWN). Meningiomas, often linked to the loss of ...

BOSTON, Feb. 23, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (RNAZ), a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancers, ...

Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and immunoediting compared with single-pathway CAR-T constructs. Complete tumor ...